OGN vs VTR · P/E 3.4, rev $6.40B vs P/E 149, rev $5.83B
Organon & Co (OGN) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported VTR revenue for 2025-12-31 was $5.83B. Net income was $261.5M. Revenue was up 18.5% from 2024-12-31 to 2025-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the OGN and VTR stock pages for the full models.
Not investment advice.